Document:

Document

      620 Memorial Drive,  Cambridge, MA 02139

March 12, 2021

Luca Scavo

Re:    Employment by Evelo Biosciences, Inc.

Dear Luca,
Evelo Biosciences, Inc. is pleased to confirm its offer to employ you as the Chief Financial Officer or such other capacity as may be mutually agreed upon by the Company and you from time to time. Your effective date of hire as a regular, full-time employee is anticipated to be June 1, 2021. 
Your base salary for this position will be $415,000 per year.  Your base salary will be paid bi-weekly in equal installments and in accordance with the Company’s payroll practices and procedures.  
Also, we are pleased to offer you a signing bonus of $50,000 and restricted stock units. The cash bonus will be paid in one lump sum in a separate check on the next regularly scheduled pay date after you start employment with the Company. The cash signing bonus is taxable, and all regular payroll taxes will be withheld. In the event that you leave the Company with 12 months of your employment start, other than for cause, you will be responsible for reimbursing the Company the entire amount of the cash signing bonus.  Additionally, I will ask the Board of Directors of the Company to grant you restricted stock units for 4,545 shares of common stock of the Company. The restricted stock units will vest in full on the third anniversary of your employment start date. In all respects, the restricted stock units will be governed by the Company’s 2018  Incentive Award Plan and a restricted stock unit agreement. 

You will also be eligible to receive a target annual bonus of 40% at the sole discretion of the Board of Directors which could be adjusted by both the Company’s performance and your individual performance.  Bonuses are intended to retain valuable Company employees, and a bonus is not payable unless you are an employee of the Company on the date that such bonus is scheduled to be paid.  

In addition to your cash compensation, after your employment start date, I will ask the Board of Directors of the Company to grant you an option to purchase 300,000 shares of common stock of the Company (subject to adjustment for any stock splits, dividends, recapitalizations and the like). New hire options approved by the Board are granted with an exercise price set to the stock price at time of grant. This option will vest over a four-year period: 25% on the first anniversary of your employment start date and the remaining 75% in 36 substantially equal monthly installments thereafter. In all respects, the option will be governed by the Company’s 2018 
1

Incentive Award Plan and a stock option agreement. In addition, you will be eligible to receive long-term incentive awards periodically, at the discretion of the Board of Directors and in accordance with the Company’s incentive award program.  

In order to assist you with the expenses associated with the relocation of your permanent residence to the Boston area, the Company will provide you an allowance of $5,000 per month for temporary living and travel costs for up to 12 months after the start of your employment.

You will be eligible to participate in the Company’s standard benefit programs as they are in effect from time to time and subject to their terms.  Currently, these benefit programs include holidays, 24 days of flexible time off for vacation and sick time as well as medical insurance, dental insurance, life insurance and a 401(k) retirement plan.  Additional details of our current benefit offerings are described in the Benefits Summary, a copy of which is enclosed.  The Company reserves the right to alter or amend its employee benefit programs at any time.
As a condition of your employment, you must sign and abide by the Company’s Employee Proprietary Information, Inventions Assignment and Restrictive Covenants Agreement, a copy of which is enclosed.  As a Company employee, you will be expected to abide by Company policies and procedures as may be in effect from time to time.

It is understood that you will at all times be an “at-will” employee.  You are not being offered employment for a definite period of time, and either you or the Company may terminate the employment relationship at any time and for any reason without prior notice and without additional compensation to you.
Your normal place of work will initially be 620 Memorial Drive, Cambridge, Massachusetts  02139; however, it is understood that the Company may change your normal place of work according to the Company’s future needs.    

In making this offer, the Company understands, and in accepting it you represent that you are not under any obligation to any former employer or any person, firm, or corporation which would prevent, limit, or impair in any way the performance by you of your duties as an employee of the Company.
The Immigration Reform and Control Act requires employers to verify the employment eligibility and identity of new employees.  This offer of employment is contingent upon your providing satisfactory documentation of these matters.  Enclosed is a copy of the Form I-9 that you will be required to complete.  Please bring the appropriate documents listed on that form with you when you report for work.  We will not be able to employ you if you fail to comply with this requirement. 
This Letter, along with the Employee Proprietary Information Agreement, sets forth the complete and exclusive agreement between you and the Company with regard to your employment with the Company, and supersedes any prior representations or agreements about this matter, whether 
                                      2    

written or verbal.  This Letter may not be modified or amended except by a written agreement signed by you and an authorized representative of the Company.  
Please indicate your acceptance of this offer by signing and dating this letter and returning it by March 19, 2021, after which date this offer will expire.
We look forward to your joining the Company and are pleased that you will be working with us.
Very truly yours,
Evelo Biosciences, Inc.
/s/ Balkrishan Simba Gill
Balkrishan ‘Simba’ Gill
Accepted and Agreed:
    /s/ Luca Scavo                
Luca Scavo

    March 13, 2021                
Date:
                                      3Exhibit 10.1

 

Schedule of Omitted Documents and Terms

 

The Form of Stock
Award Agreement attached to this Quarterly Report on Form 10-Q was entered into between the Company and certain Directors to formalize
compensation for service as a member of the Board of Directors. The below chart identifies the relevant documents omitted from this Quarterly
Report on Form 10-Q and material deviations from the Form of Stock Award Agreement attached hereto.

 

	 

                                                                                Document
Omitted
 	Terms of Award
	 

                                                                                                                                                   Stock
Award Agreement, dated June 14, 2022, between the Company and Paul Montalbano

                                                                                                                                                    
	22,728 Shares of Common Stock
	 

                                                                                Stock Award Agreement, dated June 14, 2022, between the Company and Jonathan Berger

                                                                                 
	22,728 Shares of Common Stock
	 

                                                                                Stock
Award Agreement, dated June 14, 2022, between the Company and Jeffrey Cozad

                                                                                 
	22,728 Shares of Common Stock
	 

                                                                                Stock Award Agreement, dated June 14, 2022, between the Company and Pratap Mukharji

                                                                                 
	22,728 Shares of Common Stock
	 

                                                                                Stock Award Agreement, dated June 14, 2022, between the Company and Jeff Garwood

                                                                                 
	22,728 Shares of Common Stock
	 

                                                                                Stock Award Agreement, dated June 14, 2022, between the Company and Brian Ruden

                                                                                 
	22,728 Shares of Common Stock
	 

                                                                                Stock Award Agreement, dated June 14, 2022, between the Company and Salim Wahdan

                                                                                 
	14,584 Shares of Common Stock
	 

                                                                                                                                                   Stock
Award Agreement, dated June 24, 2022, between the Company and Salim Wahdan

                                                                                                                                                    
	15,586 Shares of Common Stock

 

 

 

 

 

    	 	1	 

     

    

 

Medicine Man Technologies, Inc.

2017 Equity Incentive Plan

 

Stock
Award Agreement

 

This Stock Award Agreement (this “Agreement”)
is made and entered into as of [DATE], by and between Medicine Man Technologies, Inc., d/b/a Schwazze, a Nevada corporation (the
“Company”), and [DIRECTOR NAME], who is a member of the Board of Directors of the Company (the “Participant”)
under and in accordance with the Medicine Man Technologies, Inc. 2017 Equity Incentive Plan, as amended (the “Plan”).

 

1.                  
Award of Shares.

 

1.1              
Grant. The Company hereby grants to the Participant this Stock Award, for service as a director of the Company previously
rendered and to be rendered during the year in which this Agreement is executed. Pursuant to this Stock Award, the Participant is entitled
to receive the number of shares of Common Stock of the Company equal to the “Determined Amount.” For purposes of this
Agreement and the Plan, the “Determined Amount” means the number of shares of Common Stock (rounded down to the nearest
whole share) equal to (a) $[__] divided by (b) the closing price of the Common Stock on [DATE]. For clarity, this Agreement
hereby makes an award of [__] shares of Common Stock (that is, $[__] divided by $[SHARE PRICE]) to the Participant
(the “Awarded Shares”).

 

1.2              
Consideration.
The Stock Award being made pursuant to this Agreement and under the Plan is intended to (a) attract and retain highly qualified individuals
to serve as directors of the Company, (b) increase non-employee directors’ stock ownership in the Company and (c) align non-employee
directors’ financial interests more closely with those of the stockholders of the Company.

 

1.3              
Plan Document Governs.
The Awarded Shares and this Agreement are subject to all of the applicable terms and conditions of the Plan as approved by the Company’s
stockholders. The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by reference.
In the event of a conflict between any term or provision contained in this Agreement and a term or provision of the Plan, the applicable
terms and provisions of the Plan will govern and prevail. Capitalized words and phrases used but not defined herein will have the meaning
ascribed to them in the Plan.

 

1.4              
Additional Agreements. Participant agrees upon request to execute any further documents or instruments necessary or desirable
in the sole determination of the Company to carry out the purposes or intent of the Award.

 

2.                  
Payment for the Awarded Shares. The Participant shall not be required to make any payment for the Awarded Shares granted
under this Agreement.

 

3.                  
Vesting. Subject to the transfer restrictions under this Agreement, the Plan and the Company’s governing documents,
the Participant shall have full beneficial ownership of, and rights and privileges of a shareholder as to Awarded Shares, including the
right to vote and the right to receive dividends.

 

 

 

    	 	2	 

     

    

 

4.                  
Issuance of Shares.

 

4.1              
Timing of Issuance. As soon as administratively practicable after this Agreement is fully executed, the Company shall issue
the shares of Common Stock representing the Awarded Shares registered in the name of the Participant, the Participant’s authorized
assignee, or the Participant’s legal representative, which issuance shall be evidenced by stock certificates representing the shares
with the appropriate legends affixed thereto, appropriate entry on the books of the Company or of a duly authorized transfer agent, or
other appropriate means as determined by the Company.

 

4.2              
Issuance Subject to Government and Other Regulations. The obligation of the Company to deliver the shares of Common
Stock awarded under this Agreement and the Plan shall be subject to all applicable laws, rules and regulations and such approvals by any
governmental agencies or regulatory authorities as may be required or be deemed necessary or appropriate by counsel for the Company.

 

5.                 
Stockholder Rights. The Participant shall not have any rights as a stockholder of the Company with respect to the Awarded
Shares of Common Stock unless and until certificates representing the shares have been issued by the Company to the Participant as the
holder of such shares, or the shares have otherwise been recorded on the books of the Company or of a duly authorized transfer agent as
owned by such holder.

 

6.                  
Limitations on Transfer.

 

6.1              
Transferability. The Participant will not sell, assign, hypothecate, donate, encumber or otherwise dispose of any interest
in the Awarded Shares except in compliance with this Agreement, the Company’s bylaws, any stockholders’ agreement that the
Participant may be required to execute, applicable securities laws or Company or underwriter trading policies. For clarity, no sale, transfer
or other disposition of the Awarded Shares or any interest in the Awarded Shares may occur unless the Company has first determined that
such sale, transfer or other disposition is permitted by applicable securities laws (even if otherwise allowed by this Agreement and the
Company’s corporate governance documents).

 

6.2              
Restrictive Legends. Certificates for the Awarded Shares may include any legend which the Company deems appropriate to reflect
any or all of the applicable restrictions on transfers.

 

6.3              
Stop-Transfer Orders. The Participant agrees that, in order to ensure compliance with the restrictions referred to herein
and the Plan, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the
Company transfers its own securities, it may make appropriate notations to the same effect in its own records. In addition, the Company
shall not be required (i) to transfer on its books any Awarded Shares that have been sold or otherwise transferred in violation of any
of the provisions of this Agreement or the Plan or other governing document or (ii) to treat as the owner or to accord the right to vote
or pay dividends to any purchaser or other transferee to whom such Awarded Shares shall have been so transferred.

 

7.                 
Adjustments. If the outstanding Common Stock shall at any time be changed or exchanged by exchanges of shares, recapitalization,
merger, consolidation or other corporate reorganization in which the Company is the surviving corporation, the number of Awarded Shares
may be adjusted or terminated in any manner as contemplated by Section 11 of the Plan.

 

 

 

    	 	3	 

     

    

 

8.                  
Withholding; Tax Liability.

 

8.1              
Withholding.
If the Company, in its discretion, determines that it is obligated to withhold any tax in connection with the grant of the Awarded Shares
to the Participant, the Participant must make arrangements satisfactory to the Company to pay or provide for any applicable federal, state
and local withholding obligations of the Company. The Participant may satisfy any federal, state or local tax withholding obligation relating
to the Awarded Shares by any of the following means or by a combination of such means: (a) tendering a cash payment; (b) authorizing the
Company to withhold shares of Common Stock from the shares of Common Stock otherwise issuable to the Participant as a result of the award
made pursuant to this Agreement; provided, however, that no shares of Common Stock are withheld with a value exceeding the minimum
amount of tax required to be withheld by law; or (c) delivering to the Company previously owned and unencumbered shares of Common Stock.
The Company has the right to withhold taxes from any compensation paid to a Participant.

 

8.2              
Notwithstanding any action the Company takes with respect to any or all income tax, social insurance, payroll tax, or other tax-related
withholding (“Tax-Related Items”), the ultimate liability for all Tax-Related Items is and remains the Participant’s
responsibility and the Company (a) makes no representation or undertakings regarding the treatment of any Tax-Related Items in connection
with the grant, vesting, or any other action related to the Awarded Shares or the subsequent sale of any of the Award Shares and (b) does
not commit to structure the award made under this Agreement and pursuant to the Plan to reduce or eliminate the Participant’s liability
for Tax-Related Items.

 

8.3              
The Participant understands and agrees that (a) the Company will only recognize the Participant as a record holder of the Awarded
Shares if the Participant has paid or made, prior to any relevant taxable or tax withholding event, as applicable, adequate arrangements
satisfactory to the Company to satisfy any withholding obligation the Company may have for Tax-Related Items and (b) the Company has no
obligation to deliver the Awarded Shares to or on behalf of the Participant until the Participant has satisfied the obligations in connection
with the Tax-Related Items.

 

9.                 
Leak Out. All shares of Common Stock issued pursuant to this Agreement may be liquidated at a daily rate of no more than 5% of the
preceding 5 day average volume of the Company’s Common Stock on any given trading day.

 

10.             
Award Subject to Company Clawback or Recoupment. To the extent permitted by applicable law, the Awarded Shares shall be subject to
clawback or recoupment pursuant to any compensation clawback or recoupment policy adopted by the Board or required by law during the term
of your employment or other service that is applicable to the Participant. In addition to any other remedies available under such policy,
applicable law may require the cancellation of this Stock Bonus Award and the recoupment of any gains realized with respect to the Stock
Bonus Award described in this Agreement.

 

11.             
Compliance with Law. The issuance and transfer of shares of Common Stock pursuant
to this Agreement shall be subject to compliance by the Company and the Participant with all applicable requirements of federal and state
securities laws, regulatory agencies and any stock exchange or other trading market on which the Company’s shares of Common Stock
may be listed or quoted. No shares of Common Stock shall be issued pursuant to this Agreement unless and until any then applicable requirements
of state or federal laws and regulatory agencies have been fully complied with to the satisfaction of the Company and its counsel. The
Participant understands that the Company is under no obligation to register the shares of Common Stock with the U.S. Securities and Exchange
Commission, any state securities commission or any stock exchange to effect such compliance.

 

12.             
Notices. Any notice required to be delivered to the Company under this Agreement
shall be in writing and addressed to the General Counsel of the Company at the Company’s principal corporate offices. Any notice
required to be delivered to the Participant under this Agreement shall be in writing and addressed to the Participant at the Participant’s
address as shown in the records of the Company. Either party hereto may designate another address in writing (or by such other method
approved by the Company) from time to time.

 

 

 

    	 	4	 

     

    

 

13.              
Governing Law. This Agreement will be governed by, construed
and enforced in accordance with the internal laws of the State of Nevada without regard to conflict of law principles.

 

14.              
Venue and Jurisdiction. Notwithstanding Section 13 of this Agreement and Section 12(E) (“Choice of Law”) of
the Plan, except as the laws of the United States may otherwise require, any and all disputes relating to or arising under this Agreement
to enforce this Agreement shall be brought by civil action and resolved only in the United States District Court for the District of Colorado
(the “Court”), which shall have and retain continuing and exclusive jurisdiction over this Agreement. The Participant,
by virtue of his or her participation in the Plan, irrevocably consents to the jurisdiction and venue in the Court, and that any and all
disputes shall be adjudicated solely by the Court, and further irrevocably waive any objection or defense based on lack of venue, personal
jurisdiction, forum non conveniens, transfer, priority doctrines, and any defense(s) of similar type or import.

 

15.             
Interpretation. This Agreement constitutes the entire agreement between the parties hereto pertaining to the subject matter
hereof and supersedes all prior and contemporaneous agreements, representations and understandings. Any dispute regarding the interpretation
of this Agreement shall be submitted by the Participant or the Company to the full Board for review. The resolution of such dispute by
the Board shall be final and binding on the Participant and the Company.

 

16.             
Successors and Assigns. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon
and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this
Agreement will be binding upon the Participant and the Participant’s beneficiaries, executors, administrators and the person(s)
to whom this Agreement may be transferred by will or the laws of descent or distribution.

 

17.             
Discretionary Nature of Plan. The Plan is discretionary and may be amended,
cancelled or terminated by the Company at any time, in its discretion. The grant of the Stock Award in this Agreement does not create
any contractual right or other right to receive any shares of Common Stock or other Awards in the future. Future Awards, if any, will
be at the sole discretion of the Company. Any amendment, modification, or termination of the Plan shall not constitute a change or impairment
of the terms and conditions of the Participant’s service with the Company.

 

18.             
Amendment. The Board has the right to amend, alter, suspend, discontinue or
cancel this Award made pursuant to this Agreement, prospectively or retroactively; provided, that, no such amendment shall adversely
affect the Participant’s material rights under this Agreement without the Participant’s consent.

 

19.              
Acknowledgement and Acceptance.
The Participant hereby acknowledges receipt of a copy of the Plan together with this Agreement, and any applicable Plan prospectus. The
Participant represents that he or she has read and understands the terms and provisions thereof, and accepts this Award subject to all
of the terms and conditions of the Plan and this Agreement. The Participant acknowledges that there may be adverse tax consequences upon
receipt of the shares of Common Stock issued pursuant to this Agreement or disposition of the shares of Common Stock and that the Participant
should consult the Participant’s personal tax advisor prior to such receipt or disposition. In accepting this Award and executing
this Agreement, the Participant agrees to accept as binding, conclusive and final all decisions or interpretations of the Company upon
any questions relating to the Plan and this Agreement.

 

20.             
Severability. The invalidity or unenforceability of any provision of the Plan or this Agreement shall not affect the validity
or enforceability of any other provision of the Plan or this Agreement, and each provision of the Plan and this Agreement shall be severable
and enforceable to the extent permitted by law.

 

21.             
Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which,
when taken together, will constitute one and the same instrument. Counterpart signature pages to this Agreement transmitted by facsimile
transmission, by electronic mail in portable document format (.pdf), or by any other electronic means intended to preserve the original
graphic and pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing an original
signature.

 

[Remainder of Page Intentionally
Left Blank;

Signature Page Follows]

 

 

 

 

 

 

 

    	 	5	 

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed and delivered as of the date first above written notwithstanding the actual date
of signing.

 

	 	COMPANY:
	 	 
	 	Medicine Man Technologies, Inc., d/b/a/ Schwazze,
	 	a Nevada corporation
	 	 
	 	By:       ________________________________
	 	 
	 	Name:       ______________________________
	 	 
	 	Title:       _______________________________

	 	 
	 	 
	 	 
	 	PARTICIPANT:
	 	 
	 	______________________________________
	 	 
	 	Printed Name: ___________________________

 
 

CONSENT OF SPOUSE OR REPRESENTATION OF UNMARRIED
STATUS

 

Consent of Spouse: The undersigned
spouse of the Participant has read and hereby approves the foregoing Stock Award Agreement. In consideration of the Company’s granting
the Participant the right to acquire the Awarded Shares in accordance with the terms of the Stock Award Agreement, the undersigned hereby
agrees to be irrevocably bound by all the terms of the Stock Award Agreement, including (without limitation) the right of the Company
(or its assigns) to take actions that may affect the Participant’s ownership of the Awarded Shares.

 

	
    ______________________________________

    Spouse’s Signature

                                           

                                          ______________________________________

    

    Spouse’s Printed Name
	Dated as of ____________________, 2022

♦ ♦ ♦

Representation of Unmarried Status:
By signing below, I, the above-named Participant, represent that, as of the Effective Date, I am single and not married, including under
common law.

 

	 	______________________________________
	 	 
	 	Printed Name: ___________________________
	 	 
	 	Date: _________________________________

 

 

 

    	 	6	 

     

    

 

Medicine Man Technologies, Inc. 2017 Equity
Incentive Plan, as amended

 

[Attached]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	7	 

     

    

 

Amended and Restated Prospectus

 

[Attached]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]